| Title |
Mortality Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment
|
|---|---|
| Published in |
Drug Safety, November 2012
|
| DOI | 10.2165/11317630-000000000-00000 |
| Pubmed ID | |
| Authors |
Suzanne McCarthy, Noel Cranswick, Laura Potts, Eric Taylor, Ian C. K. Wong |
| Abstract |
Following reports of sudden death in patients taking medication to treat attention-deficit hyperactivity disorder (ADHD), this study aimed to identify cases of death in patients prescribed stimulants and atomoxetine and to determine any association between these and sudden death. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | 25% |
| Bosnia and Herzegovina | 1 | 13% |
| Unknown | 5 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 63% |
| Practitioners (doctors, other healthcare professionals) | 2 | 25% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 115 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 26 | 22% |
| Student > Master | 19 | 16% |
| Student > Ph. D. Student | 12 | 10% |
| Student > Bachelor | 11 | 9% |
| Student > Doctoral Student | 9 | 8% |
| Other | 22 | 18% |
| Unknown | 21 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 33% |
| Psychology | 25 | 21% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Economics, Econometrics and Finance | 3 | 3% |
| Social Sciences | 3 | 3% |
| Other | 15 | 13% |
| Unknown | 30 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2024.
All research outputs
#2,904,845
of 25,884,216 outputs
Outputs from Drug Safety
#314
of 1,880 outputs
Outputs of similar age
#26,586
of 287,951 outputs
Outputs of similar age from Drug Safety
#105
of 817 outputs
Altmetric has tracked 25,884,216 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,880 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,951 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 817 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.